Cite

HARVARD Citation

    Ryland, G. et al. (2020). Inotuzumab ozogamicin resistance associated with a novel CD22 truncating mutation in a case of B‐acute lymphoblastic leukaemia. British journal of haematology. pp. 123-126. [Online]. 
  
Back to record